We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$426M
Cap. Flow
+$459M
Cap. Flow %
39.34%
Top 10 Hldgs %
6.63%
Holding
2,667
New
887
Increased
542
Reduced
345
Closed
877

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12.6M
2
META icon
Meta Platforms (Facebook)
META
+$9.1M
3
MSFT icon
Microsoft
MSFT
+$8.07M
4
CVX icon
Chevron
CVX
+$5.32M
5
DECK icon
Deckers Outdoor
DECK
+$4.36M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.1M
2
GE icon
GE Aerospace
GE
+$3.43M
3
AZO icon
AutoZone
AZO
+$3.1M
4
MS icon
Morgan Stanley
MS
+$2.66M
5
BKR icon
Baker Hughes
BKR
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Industrials 14.87%
3 Healthcare 14.62%
4 Consumer Discretionary 13.4%
5 Financials 12.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCAT icon
1476
Red Cat Holdings
RCAT
$1.13B
$67.7K 0.01%
58,895
+46,897
+391% +$50.5K
UUUU icon
1477
Energy Fuels
UUUU
$2.83B
$66.7K 0.01%
11,000
-17,166
-61% -$105K
MGX icon
1478
Metagenomi Therapeutics
MGX
$45.6M
$66.3K 0.01%
+16,244
New +$112K
XFOR icon
1479
X4 Pharmaceuticals
XFOR
$371M
$64.5K 0.01%
+3,708
New +$121K
ARQ icon
1480
Arq
ARQ
$83.7M
$64.5K 0.01%
+10,623
New +$73.3K
CFFN icon
1481
Capitol Federal Financial
CFFN
$1.09B
$64.2K 0.01%
11,686
-211
-2% -$1.1K
LAB icon
1482
Standard BioTools
LAB
$311M
$63.7K 0.01%
35,965
+9,947
+38% +$24.3K
LSF icon
1483
Laird Superfood
LSF
$46.8M
$63.3K 0.01%
+11,267
New +$34.1K
KRON
1484
DELISTED
Kronos Bio
KRON
$61.9K 0.01%
49,911
+9,096
+22% +$9.26K
LCTX icon
1485
Lineage Cell Therapeutics
LCTX
$267M
$61.3K 0.01%
+61,515
New +$67.9K
SVM
1486
Silvercorp Metals
SVM
$2.08B
$61K 0.01%
18,162
-30,510
-63% -$110K
ACRV icon
1487
Acrivon Therapeutics
ACRV
$65.9M
$60.9K 0.01%
+10,493
New +$84.5K
LONA
1488
LeonaBio Inc
LONA
$65.5M
$60.1K 0.01%
+2,270
New +$53.5K
CRNC icon
1489
Cerence
CRNC
$368M
$59.8K 0.01%
+21,138
New +$151K
BTAI icon
1490
BioXcel Therapeutics
BTAI
$26.1M
$59.5K 0.01%
2,906
+955
+49% +$32K
ATER icon
1491
Aterian
ATER
$4.21M
$58.9K 0.01%
+20,974
New +$52.2K
SLAI
1492
DELISTED
SOLAI Ltd ADS
SLAI
$58.8K 0.01%
+3,184
New +$59.3K
TSVT
1493
DELISTED
2seventy bio
TSVT
$58.4K 0.01%
15,159
-3,672
-19% -$16.6K
BBAI icon
1494
BigBear.ai
BBAI
$1.32B
$58.4K 0.01%
+38,648
New +$60.4K
HEPS
1495
D-Market Electronic Services & Trading
HEPS
$1.06B
$58.1K 0.01%
+26,268
New +$44.1K
PDSB icon
1496
PDS Biotechnology
PDSB
$38.6M
$57.6K ﹤0.01%
19,654
-40,600
-67% -$130K
DDD icon
1497
3D Systems Corp
DDD
$412M
$56.8K ﹤0.01%
+18,509
New +$67.9K
ANY icon
1498
Sphere 3D
ANY
$16.8M
$56.3K ﹤0.01%
+5,213
New +$58.9K
LVTX
1499
DELISTED
LAVA Therapeutics
LVTX
$55.5K ﹤0.01%
+30,807
New +$81.3K
ANGI icon
1500
Angi Inc
ANGI
$252M
$55.3K ﹤0.01%
2,882
-10,382
-78% -$225K

Similar funds

XTX Topco's Q2 2024 Portfolio in Review

As of Q2 2024, XTX Topco held 2,667 positions worth $1.17B, up 57% from $742M the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

XTX Topco deployed $459M of net new capital in Q2 2024, opening 887 new positions and adding to 542 existing holdings. Its largest new stake was RTX Corp: 40,074 shares worth $4.02M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was GE Aerospace, an estimated $3.43M trimmed.

  • XTX Topco's largest Q2 2024 buy was RTX Corp: 40,074 shares worth $4.02M.
  • XTX Topco added most to Apple in Q2 2024, an estimated $12.6M increase.
  • XTX Topco's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $3.43M.
  • XTX Topco fully exited Tesla in Q2 2024, selling an estimated $4.1M.
  • XTX Topco's ten largest holdings make up 6.6% of its $1.17B portfolio in Q2 2024.
  • XTX Topco opened 887 new positions and closed 877 in Q2 2024.
  • XTX Topco's portfolio value rose 57% quarter-over-quarter to $1.17B.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.